Laboratory Corp of America Holdings (USD)
LH
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range170.23 | 172.40
52-Wk Range119.38 | 178.44
Last Close171.82
Mkt Cap (m)16,683.72
Dividend yield-
ISINUS50540R4092
Volume437,438
Exchange VenueNYS

Company Profile

Laboratory Corp of America Holdings is a healthcare diagnostics company. It is engaged in providing comprehensive clinical laboratory and end-to-end drug development services. It operates in two segments: LabCorp Diagnostics and Covance Drug Development.

Key Information
Price/Earning22.58
Price/Book2.31
Price/Sales1.50
P/CF12.54
Rev Growth (3 year avg)9.30
EPS Growth (3 year avg)0.26
Operating Margin % 12.12
Net Margin %7.80
Return on Equity12.81
Debt/Equity0.87

Legal Documents

Prospectus
en 19/11/2019
Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)5,8086,0128,6809,64210,44111,333
Operating Income (m)1,0139281,1171,3711,4351,374
Net Income (m)5745114377321,268884
Basic EPS6.366.034.427.1412.398.71
Avg. Diluted Shares Outstanding (m)9286101104104103
Balance Sheet
USD201320142015201620172018
Current Assets (m)1,4321,6932,6632,4792,6832,835
Non Current Assets (m)5,5345,60911,55911,76813,88513,350
Total Assets (m)6,9667,30214,22214,24716,56816,185
Current Liabilities (m)7369761,7021,8282,0461,879
Total Liabilities (m)------
Total Equity (m)2,4912,8214,9445,5066,8306,971
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)8197399821,1761,4591,305
Capital Expenditure (m)-202-204-256-279-315-380
Figures are quoted in USD unless stated otherwise
-0.90 (-0.52%)
$
170.92
Last Price